In a follow-up to our November CEO profile, Novo Nordisk’s Jesper Høiland writes how pharma companies and insurers are learning to collaborate.
Jesper Hoiland
Advertisement
Articles by Jesper Hoiland
Advertisement
Latest Updated Articles
Beyond the Blame Game: How Pharma is Learning to CollaboratePublished: January 13th 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
AbbVie Raises 2025 Profit Forecast Following Increased Demand for Immunology Treatments
2
ClipNotes: AI Built for Pharma: Why Out-of-the-Box Beats Build-From-Scratch
3
Tylenol Maker Sued While Kennedy Says No ‘Sufficient’ Evidence for Autism Link
4
Novo Nordisk’s Unsolicited Proposal to Acquire Metsera
5
